semaglutide discontinuation effects Majority of adults with obesity discontinue Wegovy within 1 year Woman shares journey of weight

144 The prevalence of sudomotor dysfunction in diabetes patients is approximately 30%

Daily weights and symptom tracking are far better guides for adjustment than rigid, one-size-fits-all rules

With the development of more sensitive and specific indicators of liver disease, dye excretion tests have become obsolete

Spicy foods: These can irritate the esophageal lining

In vitro studies suggest GHK-Cu may stimulate collagen synthesis and fibroblast activity

As of January 2026, Health Canada is reviewing nine submissions for generic semaglutide from companies including: Health Canada's target review timeline is 180 days, though complex submissions can take longer